Skip to main content

Table 4 The serum expression level of FGA, APOA-1 and AHSG in different groups

From: Identification of serum proteins AHSG, FGA and APOA-I as diagnostic biomarkers for gastric cancer

 

Control group (n = 28)

I/II GC-pre (n = 16)

III/IV GC-pre (n = 26)

I/II GC-post (n = 16)

III/IV GC-post (n = 26)

CRC (n = 30)

HCC (n = 30)

FGA (ng/ml)

406.80 ± 42.52 (330.14–490.51)

544.05 ± 53.74 (447.79–642.26)

814.19 ± 85.74 (676.96–950.09)

403.54 ± 46.80 (428.47–598.98)

664.13 ± 63.38 (556.04–755.03)

630.94 ± 96.46 (429.35–800.72)

596.70 ± 67.63 (450.21–779.29)

AHSG (μg/ml)

291.83 ± 47.24 (204.48–375.66)

353.74 ± 49.51 (244.96–441.11)

455.79 ± 59.74 (385.38–606.92)

324.74 ± 41.81 (244.41–401.99)

420.17 ± 53.98 (354.95–548.11)

337.34 ± 49.78 (224.17–423.79)

351.26 ± 41.66 (262.71–441.91)

AOPA-I (μg/ml)

3.44 ± 0.96 (2.03–5.44)

5.91 ± 1.19 (4.66–8.23)

3.71 ± 0.79 (2.67–6.19)

4.52 ± 1.14 (3.21–6.92)

3.31 ± 0.82 (1.97–5.02)

3.82 ± 0.65 (2.80–5.67)

2.25 ± 0.93 (0.84–4.10)